Sentences with phrase «with measured results»

Show Accomplishments with Measured Results.

Try your best to back - up your accomplishments with measured results.

Just as you may have done with your prior resume, uncover major accomplishments with measured results.

Each bulleted statement should be a strong accomplishment, complete with measured results whenever possible.

Go beyond the job description and share achievements with measured results.

Sharpen your message to include accomplishments with measured results and each time you send your resume, align it with your job target.

There was no way within the system to give credit for important goals not directly aligned with the measured results.

On what planet is it ok to publish modelling results without even a passing attempt to determine how these correlate with measured results!

I was consumed with measuring the results we got for our B2B organizations.

Not exact matches

These adjusted measures are not intended to replace the presentation of our financial results in accordance with GAAP.

In addition to the results provided in accordance with US Generally Accepted Accounting Principles («GAAP») in this press release, the Company provides measures adjusted for Special Items, which include Adjusted Operating Profit, Adjusted Diluted Earnings Per Common Share, Adjusted Effective Tax Rate and Adjusted EBITDA, which we define as net income including noncontrolling interests adjusted for income tax, interest income, depreciation, amortization and other items, including store impairment charges.

Google is aware that slow sites make for a poor user experience, and because they can measure site speed with their crawls and poor user experience by the number of people that immediately return to their results pages after clicking on a link, site speed is an important ranking factor.

The process is fairly simple: Extract the cell's DNA, measure its carbon - 14 levels with a tool called a mass spectrometer, and check the result against tables of carbon - 14 decay in the period since 1963.

MTS believes that non-GAAP financial measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.

His firm estimated that $ 75 billion in insured losses would result in an average industry - wide combined ratio, a closely - watched measure of expenses to premium income, of 106 percent compared with 95 percent in 2016.

For more details on T - Mobile's Q1 2018 financial results, including the Investor Factbook with detailed financial tables and reconciliations of certain historical non-GAAP measures disclosed in this release to the most comparable measures under GAAP, please visit T - Mobile US, Inc.'s Investor Relations website at http://investor.t-mobile.com.

These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

He notes that while the tools available for identifying raw talent made gains with performance - measuring software and online recruitment tools, the results of these searches has hardly improved.

However, Non-GAAP measures should not be considered as substitutes for operating income, net income or other data prepared and reported in accordance with GAAP and should be viewed in addition to our reported results prepared in accordance with GAAP.

We report our financial results in accordance with GAAP, but believe that certain non-GAAP financial measures provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period - over-period comparisons of those operations.

The non-GAAP results should not be considered a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from non-GAAP measures used by other companies.

With weak results in wireless at Verizon — revenue fell 5 % and an adjusted profit measure fell almost 8 % for the quarter in the unit — those fears may only grow.

Use and Definitions of Non-GAAP Financial Measures United Technologies Corporation reports its financial results in accordance with accounting principles generally accepted in the United States («GAAP»).

As with every marketing effort, experiential marketing should be carefully measured, with the results applied to future campaigns.

These non-GAAP measures should only be used to evaluate Cree's results of operations in conjunction with the corresponding GAAP measures.

Says Sonsoles Gonzalez, a former general manager for Pantene who left in 2011: «There was lots and lots of measuring for the purpose of promoting productivity, but it resulted in too many internal transactions and negotiations and had less to do with winning the consumer.»

By publishing the non-GAAP measures, management intends to provide investors with additional information to further analyze the Company's performance, core results and underlying trends.

This number should be the result of a complete analysis of your marketing and sales activities, so your ability to project this number with accuracy is a key measure of your talent as a businessperson.

The Company uses the non-GAAP financial measures set forth in the news release in connection with its own budgeting and financial planning internally to evaluate the performance of the business, including to allocate resources and to evaluate results relative to incentive compensation targets.

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides non-GAAP measures that adjust for the impacts of the NRD resolution and measurement period adjustment to the impact of enactment of the TCJA.

The Alaska measure led by about 52 - 48 percent with all precincts reporting preliminary results early on Wednesday, and groups for and against the initiative said it had passed.

Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the company's results of operations as determined in accordance with GAAP.

The Company believes that discussion of these additional non-GAAP measures provides investors with meaningful comparisons of current results to prior periods» results by excluding items that the Company does not believe reflect its fundamental business performance.

The company has provided these non-GAAP financial measures in addition to GAAP financial results because it believes that these non-GAAP adjusted financial measures provide investors with a better understanding of the company's historical results from its core business operations.

By disclosing these non-GAAP measures, we intend to provide investors with a consistent comparison of our operating results and trends for the periods presented.

The Company believes that the presentation of non-GAAP measures when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and its historical and projected results of operations.

The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with Harmonic's results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Harmonic's results of operations in conjunction with the corresponding GAAP measures.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Non-GAAP financial measures should be viewed in addition to, and not as an alternative to, the Company's reported results prepared in accordance with GAAP.

Use of Non-GAAP Financial Results This release includes measures that are not in accordance with U.S. generally accepted accounting principles («non-GAAP measures»).

The best leaders I work with are implementing programs like OKRs (objectives & key results) or a version of V2MOM (vision, values, methods, obstacles & measures) popularized at Salesforce.com.

It's hard to directly measure the results of your branding efforts; you can't calculate a brand ROI the way you can with just a social media marketing or just an SEO strategy.

NEW YORK and MOUNTAIN VIEW, Calif. — October 6, 2016 — Upwork in partnership with Freelancers Union today released the results of «Freelancing in America: 2016,» the most comprehensive measure of the U.S. independent workforce.

Here, for example, are the results of surveys by the Pew Research Center, which found strong support for measures ranging from an assault weapons ban to universal background checks to restrictions on people with mental illness buying guns.

In an interview with Nav co-founder and CEO, Levi King, he suggested the link to monitoring your credit profile and positive results was measured by their American Dream Gap Report: «[B] usinesses that regularly monitor their credit were 41 percent more likely to be approved when applying for a small business loan.»

Part of this growth is temporary, related to the measures in the Economic Action Plan, with the result that the employment levels should decline once the stimulus measures terminate at the end of 2011 - 12.

As a result, starting valuations, on historically reliable measures, are 90 % correlated with actual subsequent 10 - year total market returns.

Because of these limitations, you should consider Adjusted Revenue alongside other financial performance measures, including total net revenue and our financial results presented in accordance with GAAP.

With such a measure, regulation may be possible to encompass more individuals engaged in the practice, which will likely result in a greater degree of consumer protection.

Had Trump taken the measures suggested repeatedly by ethics experts on both sides of the political aisle, he would by now have put his assets in what's called a blind trust, which would entail turning over his empire to a third party with whom he will have no contact, who would sell off the properties and reinvest the resulting money in other assets without providing the president any information about the sales or the purchases.